JP2013530208A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013530208A5 JP2013530208A5 JP2013517583A JP2013517583A JP2013530208A5 JP 2013530208 A5 JP2013530208 A5 JP 2013530208A5 JP 2013517583 A JP2013517583 A JP 2013517583A JP 2013517583 A JP2013517583 A JP 2013517583A JP 2013530208 A5 JP2013530208 A5 JP 2013530208A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- topical administration
- administration
- day
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 17
- 238000011200 topical administration Methods 0.000 claims 11
- 239000002202 Polyethylene glycol Substances 0.000 claims 5
- 229920001223 polyethylene glycol Polymers 0.000 claims 5
- 208000004898 Herpes Labialis Diseases 0.000 claims 3
- 206010067152 Oral herpes Diseases 0.000 claims 3
- 230000001815 facial effect Effects 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36232910P | 2010-07-08 | 2010-07-08 | |
| US61/362,329 | 2010-07-08 | ||
| PCT/IB2011/001919 WO2012004669A1 (en) | 2010-07-08 | 2011-07-08 | Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013530208A JP2013530208A (ja) | 2013-07-25 |
| JP2013530208A5 true JP2013530208A5 (OSRAM) | 2014-07-31 |
| JP5858994B2 JP5858994B2 (ja) | 2016-02-10 |
Family
ID=44588123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013517583A Active JP5858994B2 (ja) | 2010-07-08 | 2011-07-08 | 口唇ヘルペス、性器ヘルペス、および帯状疱疹の再発を抑制するためのポリエチレングリコール組成物 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US9814743B2 (OSRAM) |
| EP (1) | EP2563374B1 (OSRAM) |
| JP (1) | JP5858994B2 (OSRAM) |
| KR (1) | KR101881175B1 (OSRAM) |
| CN (1) | CN103079574B (OSRAM) |
| AU (1) | AU2011275458B2 (OSRAM) |
| CA (1) | CA2803228C (OSRAM) |
| DK (1) | DK2563374T3 (OSRAM) |
| ES (1) | ES2442928T3 (OSRAM) |
| HR (1) | HRP20140135T1 (OSRAM) |
| IL (1) | IL223582A (OSRAM) |
| MX (1) | MX2012014783A (OSRAM) |
| PL (1) | PL2563374T3 (OSRAM) |
| PT (1) | PT2563374E (OSRAM) |
| RS (1) | RS53162B (OSRAM) |
| RU (1) | RU2643763C2 (OSRAM) |
| SG (1) | SG186937A1 (OSRAM) |
| SI (1) | SI2563374T1 (OSRAM) |
| WO (1) | WO2012004669A1 (OSRAM) |
| ZA (1) | ZA201300177B (OSRAM) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS53162B (sr) | 2010-07-08 | 2014-06-30 | Devirex Ag | Polietilen glikolni preparati u kontroli relapsa herpes labialis-a, herpes genitalis-a i herpes zoster-a |
| WO2013102885A1 (en) | 2012-01-06 | 2013-07-11 | Devirex Ag | Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster |
| WO2014130432A1 (en) | 2013-02-19 | 2014-08-28 | Johnson & Johnson Consumer Companies, Inc. | Methods and compositions for improving appearance and formation of scar tissue |
| ES2538335T3 (es) * | 2013-05-14 | 2015-06-19 | Najöpharm Gmbh I.G. | Combinación de ácido poliacrílico y 2-amino-2-metilpropanol para uso en el tratamiento de infecciones por herpes |
| UY37497A (es) * | 2016-11-28 | 2018-06-29 | Aicuris Anti Infective Cures Gmbh | Formulación tópica que comprende n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida |
| EP3962924A1 (en) | 2019-05-03 | 2022-03-09 | Genentech, Inc. | Methods of reducing the enzymatic hydrolysis activity rate in a composition obtained from a purification platform |
| US20210330700A1 (en) * | 2020-04-23 | 2021-10-28 | Johnson & Johnson Consumer Inc. | Methods and compositions for inhibiting influenza viruses using low molecular weight hydrophobically modified polymers and polyalkylene glycols |
| WO2021233571A1 (de) * | 2020-04-30 | 2021-11-25 | Ninoderm Ug (Haftungsbeschränkt) | Behandlungsmittel zur antiviralen therapie, applikator und verfahren zur herstellung eines behandlungsmittels |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4603122A (en) * | 1979-08-17 | 1986-07-29 | Blough Herbert A | Antiviral agent against herpes virus infections |
| GB2080682B (en) * | 1980-07-30 | 1984-03-28 | Ciba Geigy Ag | Antiherpetically active lipstick |
| EP0087161A3 (en) | 1982-02-24 | 1984-04-04 | Key Pharmaceuticals, Inc. | Isopropylmyristate 4-alkyl-2,6-(bis-tert-butyl)-phenol medicament |
| US5232700A (en) | 1990-11-14 | 1993-08-03 | The Administrators Of The Tulane Educational Fund | Methods of prophylaxis and treatment of herpes simplex lesions utilizing piracetam as the active ingredient |
| NL9500216A (nl) | 1995-02-06 | 1996-09-02 | Bio Pharma Sciences Bv | Farmaceutische samenstelling voor de behandeling van herpes. |
| US6045823A (en) * | 1996-09-19 | 2000-04-04 | Dragoco Gerberding & Co. Ag | Process for producing solid anhydrous composition, and pharmaceutical and cosmetic products comprising same |
| GB9902227D0 (en) * | 1999-02-01 | 1999-03-24 | Cipla Limited | Pharmaceutical composition for topical administration |
| US8030260B2 (en) * | 2005-03-25 | 2011-10-04 | Chemsil Silicones, Inc | Pre-shave compositions and methods of using same |
| DE202005007363U1 (de) | 2005-05-04 | 2005-07-14 | Anton Hübner GmbH & Co. KG | Gegen Herpesbläschen verwendbare Kieselsäurezusammensetzungen |
| EP2121027A2 (en) | 2007-01-17 | 2009-11-25 | Devirex AG | Cyclodextrin formulations |
| RS53162B (sr) | 2010-07-08 | 2014-06-30 | Devirex Ag | Polietilen glikolni preparati u kontroli relapsa herpes labialis-a, herpes genitalis-a i herpes zoster-a |
| WO2013102885A1 (en) | 2012-01-06 | 2013-07-11 | Devirex Ag | Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster |
-
2011
- 2011-07-08 RS RS20140058A patent/RS53162B/sr unknown
- 2011-07-08 JP JP2013517583A patent/JP5858994B2/ja active Active
- 2011-07-08 RU RU2013100383A patent/RU2643763C2/ru active
- 2011-07-08 KR KR1020137002574A patent/KR101881175B1/ko active Active
- 2011-07-08 SG SG2013000823A patent/SG186937A1/en unknown
- 2011-07-08 DK DK11754919.6T patent/DK2563374T3/da active
- 2011-07-08 PL PL11754919T patent/PL2563374T3/pl unknown
- 2011-07-08 EP EP11754919.6A patent/EP2563374B1/en active Active
- 2011-07-08 ES ES11754919.6T patent/ES2442928T3/es active Active
- 2011-07-08 PT PT117549196T patent/PT2563374E/pt unknown
- 2011-07-08 US US13/704,061 patent/US9814743B2/en not_active Expired - Fee Related
- 2011-07-08 HR HRP20140135AT patent/HRP20140135T1/hr unknown
- 2011-07-08 CN CN201180033948.1A patent/CN103079574B/zh active Active
- 2011-07-08 AU AU2011275458A patent/AU2011275458B2/en active Active
- 2011-07-08 CA CA2803228A patent/CA2803228C/en active Active
- 2011-07-08 WO PCT/IB2011/001919 patent/WO2012004669A1/en not_active Ceased
- 2011-07-08 SI SI201130086T patent/SI2563374T1/sl unknown
- 2011-07-08 MX MX2012014783A patent/MX2012014783A/es active IP Right Grant
-
2012
- 2012-12-12 IL IL223582A patent/IL223582A/en active IP Right Grant
-
2013
- 2013-01-08 ZA ZA2013/00177A patent/ZA201300177B/en unknown
-
2017
- 2017-11-06 US US15/804,961 patent/US20180055875A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013530208A5 (OSRAM) | ||
| JP2016538271A5 (OSRAM) | ||
| JP2009286795A5 (OSRAM) | ||
| BR112014014262A2 (pt) | nanopartículas; composição farmacêutica; método de administrar um ou mais agentes terapêuticos, profiláticos, e/ou diagnósticos a um paciente em necessidade dos mesmos e método de preparação das partículas. | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| EP4316488A3 (en) | Methods and compositions for treatment of attention deficit disorder | |
| HRP20180237T4 (hr) | Metode za liječenje hcv-a | |
| JP2012515184A5 (OSRAM) | ||
| WO2013101897A3 (en) | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid | |
| FI3562486T3 (fi) | Kielenalaisen deksmedetomidiinin käyttö agitaation hoidossa | |
| JP2013518057A5 (OSRAM) | ||
| WO2010084115A3 (en) | Antiviral agents | |
| JP2010222367A5 (OSRAM) | ||
| WO2012098562A3 (en) | Liquid oral compositions of lanthanum salts | |
| GEP20166488B (en) | Co-crystals and salts of ccr3-inhibitors | |
| JP2016539156A5 (OSRAM) | ||
| JP2009542581A5 (OSRAM) | ||
| UA111599C2 (uk) | Композиція каспофунгіну | |
| JP2014526559A5 (OSRAM) | ||
| HRP20191723T1 (hr) | Nukleotid dims0-150 za primjenu u liječenju kroničnog aktivnog ulceroznog kolitisa | |
| RU2013100383A (ru) | Композиции полиэтиленгликоля для контроля рецидивов лабиального герпеса, генитального герпеса и опоясывающего герпеса | |
| WO2007133796A3 (en) | Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist | |
| WO2013019091A3 (en) | A COMPOUND FOR INHIBITING 11β-HYDROXY STEROID DEHYDROGENASE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | |
| JP2015507020A5 (OSRAM) | ||
| JP2007119497A5 (OSRAM) |